Distillate Capital Partners LLC

Position in ZTS — Zoetis Inc.

CIK 1741001 CHICAGO, IL

Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$16,274,134

-$2,775,643 QoQ

Shares Held

226,470

+40.5% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.85%

of 13F equity value

Holder Rank

#179

of 1,408 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Distillate Capital Partners LLC holds $46,491,118 across 3 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (35.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc. This page	226,470	$16,274,134
2	NBIX	Neurocrine Biosciences Inc	92,592	$15,605,455
3	UTHR	UNITED THERAPEUTICS Corp	26,967	$14,611,529

All Filings in ZTS

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$16,274,134	226,470	+40.5%	Shares	Sole	2026-08-14
2026-03-31	$19,049,777	161,152	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.